CX3CR1 and amyotrophic lateral sclerosis: The analysis showed that the two noncoding variants may impact ALS risk by affecting the expression levels of CX3CR1 and TNFAIP1. The CX3CR1 gene deletion has been associated with microglia neurotoxicity and neuron loss in transgenic ALS mice [123,124].